Moderna, Inc. (BMV: MRNA)

Mexico flag Mexico · Delayed Price · Currency is MXN
900.00
-17.67 (-1.93%)
Jan 29, 2025, 9:56 AM CST
-48.70%
Market Cap 355.12B
Revenue (ttm) 99.50B
Net Income (ttm) -43.55B
Shares Out n/a
EPS (ttm) -113.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 2,630
Open 901.00
Previous Close 917.67
Day's Range 900.00 - 920.00
52-Week Range 668.72 - 2,820.00
Beta n/a
RSI 62.34
Earnings Date Feb 27, 2025

About Moderna

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vac... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Employees 5,600
Stock Exchange Mexican Stock Exchange
Ticker Symbol MRNA
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.